A Canadian advisory council studying prescription drug coverage said the federal government should create a universal, single-payer public pharmacare system, and warned that the current framework requires significant reforms.

The hospitality worker’s union UNITE HERE blasted congress for scrapping an amendment to the FY 2019 appropriations bill that would have required drug makers to include list prices in direct-to-consumer television ads.

While many of us from blue states and urban bubbles fret over some of the actions of President Donald Trump, it’s good to take a clear-eyed view of whether or not Trump and this administration has been good for the medical marketing industries. Moreover, it’s useful to consider how a “blue wave” in the midterm elections might change the dynamic.